366 related articles for article (PubMed ID: 31307537)
1. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
[TBL] [Abstract][Full Text] [Related]
2. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
[TBL] [Abstract][Full Text] [Related]
3. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
4. Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Zhu Y; Li H; Guo W; Drukker K; Lan L; Giger ML; Ji Y
Sci Rep; 2015 Dec; 5():17787. PubMed ID: 26639025
[TBL] [Abstract][Full Text] [Related]
5. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
[TBL] [Abstract][Full Text] [Related]
8. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
Arefan D; Hausler RM; Sumkin JH; Sun M; Wu S
BMC Cancer; 2021 Apr; 21(1):370. PubMed ID: 33827490
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.
Su GH; Xiao Y; You C; Zheng RC; Zhao S; Sun SY; Zhou JY; Lin LY; Wang H; Shao ZM; Gu YJ; Jiang YZ
Sci Adv; 2023 Oct; 9(40):eadf0837. PubMed ID: 37801493
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
[TBL] [Abstract][Full Text] [Related]
11. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
[TBL] [Abstract][Full Text] [Related]
12. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
[TBL] [Abstract][Full Text] [Related]
13. Identifying Associations between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center Radiogenomic Study.
Ming W; Zhu Y; Li F; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672769
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI radiogenomics: Current status and research implications.
Grimm LJ
J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
[TBL] [Abstract][Full Text] [Related]
15. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Radiogenomics: Current Status and Future Directions.
Grimm LJ; Mazurowski MA
Acad Radiol; 2020 Jan; 27(1):39-46. PubMed ID: 31818385
[TBL] [Abstract][Full Text] [Related]
17. Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
Wang J; Kato F; Oyama-Manabe N; Li R; Cui Y; Tha KK; Yamashita H; Kudo K; Shirato H
PLoS One; 2015; 10(11):e0143308. PubMed ID: 26600392
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Sutton EJ; Oh JH; Dashevsky BZ; Veeraraghavan H; Apte AP; Thakur SB; Deasy JO; Morris EA
J Magn Reson Imaging; 2015 Nov; 42(5):1398-406. PubMed ID: 25850931
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.
Lin P; Liu WK; Li X; Wan D; Qin H; Li Q; Chen G; He Y; Yang H
Clin Radiol; 2020 Jul; 75(7):561.e1-561.e11. PubMed ID: 32183997
[TBL] [Abstract][Full Text] [Related]
20. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Grimm LJ; Zhang J; Mazurowski MA
J Magn Reson Imaging; 2015 Oct; 42(4):902-7. PubMed ID: 25777181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
